New ways to treat diseases
Our group operates as a joint laboratory, a synergistic partnership between the University of Milan (UNIMI) and the National Institute of Molecular Genetics (INGM). This collaboration leverages the distinct strengths of both institutions to advance our research interests.
The central focus of our research is the development and adaptation of cutting-edge gene editing technologies for both fundamental laboratory investigations and translational therapeutic applications. We are dedicated to establishing innovative therapeutic interventions for a range of diseases, employing two complementary strategies: (i) the engineering of extracellular vesicles for efficient and targeted delivery of gene editing tools or variety of therapeutic proteins, and (ii) the precise manipulation of human lymphocyte activation and effector mechanisms to potentiate next-generation lymphocyte-based immunotherapies.
We are pleased to welcome three new members to our research group: Rana Elnady, Ivan Castello Serrano and Paola Capasso.With them on board, we now have a complete team and...
Read more
We recently had the privilege of presenting our latest research at Cold Spring Harbor Laboratory in the United States. The event offered a great opportunity to share our work, exchange...
Read more
We are very happy to welcome our new team-member! Tiziana will join the task force that aim at developing new therapeutic strategies based on engineered extracellular vesicles to target infectious...
Read more